NEW YORK (GenomeWeb) – NanoString Technologies and Cell Signaling Technology announced today that they are partnering to add CST's highly validated antibodies to NanoString's 3D Biology Protein Profiling Panels.

The companies plan to create new protein-based assays that will expand NanoString's 3D Biology product offerings. Under the terms of the deal, CST will supply antibodies for use in NanoString assays and NanoString will market and sell the assays for use with its nCounter Analysis System.

Further terms of the deal were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.